Chlorthalidone Tablets — Class II drug recall D-0610-2026
Ongoing recall by Inventia Healthcare Limited, reported 2026-06-24, distributed nationwide. Failed Dissolution Specifications
| Recall number | D-0610-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Inventia Healthcare Limited, Kalyan, India |
| Recall initiated | 2026-06-05 |
| Classified | 2026-06-22 |
| Reported by FDA | 2026-06-24 |
| Distributed | Nationwide (US) |
| Quantity | 11,460 bottles |
| Reason classes | specification failure |
| NDC | 64980-0599, 64980-0599-01, 64980-0599-10, 64980-0600, 64980-0600-01 |
| Lot numbers | RISA24001, RISB24002 |
| Expiration dates | 2027-04 |
Product
Chlorthalidone Tablets, USP, 25 mg, [100 or 1000] Tablets pr bottle, Rx only, Manufactured by: Inventia Healthcare Limited, Additional Ambernath, M.I.D.C., Ambernath (East) - 421506, INDIA. Distributed by: Risiong Pharma Holdings, Inc., East Brunswick, NJ 08816. NDC 100-tablet bottle: 64980-599-01; NDC 1000-tablet bottle: 64980-599-10
Reason for recall
Failed Dissolution Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0610-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.